FDA.reportPublic FDA data

trilaciclib 300 MG Injection

RxCUI
2479705
RxNorm name
trilaciclib 300 MG Injection
Display name
trilaciclib 300 MG Injection
Full name
trilaciclib 300 MG Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:57

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
COSELATRILACICLIBPharmacosmos Therapeutics Inc.b3179c19-78f3-4bf1-b73e-7f7638522ab12025-08-31Warnings, Adverse reactionsExact identifier
rxcui: 2479705
COSELATRILACICLIBG1 Therapeutics, Inc.4b06922c-498d-4871-a037-84a44e6a6b6c2024-02-24Warnings, Adverse reactionsExact identifier
rxcui: 2479705

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
4b06922c-498d-4871-a037-84a44e6a6b6ctrilaciclib 300 MG Injection [PSN] · trilaciclib 300 MG Injection [SCD] · trilaciclib 300 MG (as trilaciclib dihydrochloride 349 MG) Injection [SY]35These highlights do not include all the information needed to use COSELA safely and effectively. See full prescribing information for COSELA. COSELA ® (trilaciclib) for injection, for intravenous use Initial U.S. Approval: 202120240224
b3179c19-78f3-4bf1-b73e-7f7638522ab1trilaciclib 300 MG Injection [PSN] · trilaciclib 300 MG Injection [SCD] · trilaciclib 300 MG (as trilaciclib dihydrochloride 349 MG) Injection [SY]33These highlights do not include all the information needed to use COSELA safely and effectively. See full prescribing information for COSELA. COSELA ® (trilaciclib) for injection, for intravenous use Initial U.S. Approval: 202120250831